—
Summary‘Glomerulonephritis - Pipeline Review, H2 2016’, provides an overview of the Glomerulonephritis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Glomerulonephritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Glomerulonephritis and features dormant and discontinued projects.
Request a sample report @ https://www.wiseguyreports.com/sample-request/685898-glomerulonephritis-pipeline-review-h2-2016
Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global therapeutic landscape of Glomerulonephritis
- The report reviews pipeline therapeutics for Glomerulonephritis by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Glomerulonephritis therapeutics and enlists all their major and minor projects
- The report assesses Glomerulonephritis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Glomerulonephritis
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Glomerulonephritis
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Glomerulonephritis pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/685898-glomerulonephritis-pipeline-review-h2-2016
Key points in table of content
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Glomerulonephritis Overview 9
Therapeutics Development 10
Pipeline Products for Glomerulonephritis - Overview 10
Pipeline Products for Glomerulonephritis - Comparative Analysis 11
Glomerulonephritis - Therapeutics under Development by Companies 12
Glomerulonephritis - Therapeutics under Investigation by Universities/Institutes 15
Glomerulonephritis - Pipeline Products Glance 16
Late Stage Products 16
Clinical Stage Products 17
Early Stage Products 18
Glomerulonephritis - Products under Development by Companies 19
Glomerulonephritis - Products under Investigation by Universities/Institutes 21
Glomerulonephritis - Companies Involved in Therapeutics Development 22
Achillion Pharmaceuticals, Inc. 22
Alexion Pharmaceuticals Inc 23
Amyndas Pharmaceuticals LLC 24
Anthera Pharmaceuticals Inc 25
Avexxin AS 26
Biogen Inc 27
Complexa, Inc. 28
Dimerix Bioscience Pty Ltd 29
GlaxoSmithKline Plc 30
Mallinckrodt Plc 31
Omeros Corporation 32
Pfizer Inc. 33
Pharmalink AB 34
Retrophin Inc. 35
Rigel Pharmaceuticals, Inc. 36
Shire Plc 37
Toray Industries, Inc. 38
Variant Pharmaceuticals, Inc. 39
Glomerulonephritis - Therapeutics Assessment 40
Assessment by Monotherapy Products 40
Assessment by Combination Products 41
Assessment by Target 42
Assessment by Mechanism of Action 44
Assessment by Route of Administration 46
Assessment by Molecule Type 48
Drug Profiles 50
(irbesartan + propagermanium) - Drug Profile 50
Product Description 50
Get this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=685898
Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WiseGuy Research Consultant Pvt Ltd
Address: WISE GUY RESEARCH CONSULTANTS PVT LTD Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028 Maharashtra, India Ph: +91 841 198 5042 info@wiseguyreports.com
Phone: +1-646-845-9349 (US) +44 208 133 9349 (UK)t
Website: https://www.wiseguyreports.com
Release ID: 140093
Google
RSS